Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.

Stenman G.

Head Neck Pathol. 2013 Jul;7 Suppl 1:S12-9. doi: 10.1007/s12105-013-0462-z. Epub 2013 Jul 3. Review.

2.

Translocation-associated salivary gland tumors: a review and update.

Weinreb I.

Adv Anat Pathol. 2013 Nov;20(6):367-77. doi: 10.1097/PAP.0b013e3182a92cc3. Review.

PMID:
24113307
3.

Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.

Bishop JA, Yonescu R, Batista D, Begum S, Eisele DW, Westra WH.

Hum Pathol. 2013 Oct;44(10):1982-8. doi: 10.1016/j.humpath.2013.03.017. Epub 2013 Jun 14.

4.

WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.

Queimado L, Lopes CS, Reis AM.

Genes Chromosomes Cancer. 2007 Mar;46(3):215-25.

PMID:
17171686
5.

Salivary gland cancers: biology and molecular targets for therapy.

Bell D, Hanna EY.

Curr Oncol Rep. 2012 Apr;14(2):166-74. doi: 10.1007/s11912-012-0220-5.

PMID:
22246609
6.

Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers.

Stenman G, Persson F, Andersson MK.

Oral Oncol. 2014 Aug;50(8):683-90. doi: 10.1016/j.oraloncology.2014.04.008. Epub 2014 May 21. Review.

PMID:
24856188
7.

[Determination of DNA content in salivary gland tumors].

Yáñez M, Roa I, Villaseca M, Fuentealba P.

Rev Med Chil. 1997 Oct;125(10):1177-81. Spanish.

PMID:
9609036
8.

Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.

Brill LB 2nd, Kanner WA, Fehr A, Andrén Y, Moskaluk CA, Löning T, Stenman G, Frierson HF Jr.

Mod Pathol. 2011 Sep;24(9):1169-76. doi: 10.1038/modpathol.2011.86. Epub 2011 May 13.

9.

New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.

Bhaijee F, Pepper DJ, Pitman KT, Bell D.

Ann Diagn Pathol. 2011 Feb;15(1):69-77. doi: 10.1016/j.anndiagpath.2010.12.001. Review.

PMID:
21238915
10.

Salivary gland cancer: an update on present and emerging therapies.

Carlson J, Licitra L, Locati L, Raben D, Persson F, Stenman G.

Am Soc Clin Oncol Educ Book. 2013:257-63. doi: 10.1200/EdBook_AM.2013.33.257. Review.

11.

Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.

von Holstein SL.

Acta Ophthalmol. 2013 Nov;91 Thesis 6:1-28. doi: 10.1111/aos.12271.

12.

Fusion oncogenes and tumor type specificity--insights from salivary gland tumors.

Stenman G.

Semin Cancer Biol. 2005 Jun;15(3):224-35. Review.

PMID:
15826837
13.

[Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].

Fehr A, Stenman G, Bullerdiek J, Löning T.

Pathologe. 2009 Nov;30(6):466-71. doi: 10.1007/s00292-009-1206-4. German.

PMID:
19784654
14.

Expression of ras-P21 in salivary gland tumors.

Kusama K, Chu L, Suzuki T, Okutsu S, Kudo I, Moro I.

Adv Exp Med Biol. 1995;371B:1187-90. No abstract available.

PMID:
7502781
15.

Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.

Sasahira T, Kurihara M, Yamamoto K, Bhawal UK, Kirita T, Kuniyasu H.

Cancer Sci. 2011 Feb;102(2):492-7. doi: 10.1111/j.1349-7006.2010.01787.x. Epub 2010 Nov 24.

16.

Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.

von Holstein SL, Fehr A, Persson M, Nickelsen M, Therkildsen MH, Prause JU, Heegaard S, Stenman G.

Ophthalmology. 2014 May;121(5):1125-33. doi: 10.1016/j.ophtha.2013.11.037. Epub 2014 Jan 24.

PMID:
24468654
17.

Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.

Mitani Y, Liu B, Rao PH, Borra VJ, Zafereo M, Weber RS, Kies M, Lozano G, Futreal PA, Caulin C, El-Naggar AK.

Clin Cancer Res. 2016 Feb 1;22(3):725-33. doi: 10.1158/1078-0432.CCR-15-2867-T. Epub 2015 Dec 2.

18.

[A new analysis tool of salivary gland tumors: looking for specific translocations].

Uro-Coste E.

Ann Pathol. 2011 Nov;31(5 Suppl):S100-2. doi: 10.1016/j.annpat.2011.08.004. Epub 2011 Sep 9. French. No abstract available.

PMID:
22054439
19.

Clinical implication of CD166 expression in salivary gland tumor.

Andisheh-Tadbir A, Ashraf MJ, Khademi B, Ahmadi S.

Tumour Biol. 2015 Apr;36(4):2793-9. doi: 10.1007/s13277-014-2905-x. Epub 2014 Dec 4.

PMID:
25472586
20.

Cytopathologic features of mammary analogue secretory carcinoma.

Bishop JA, Yonescu R, Batista DA, Westra WH, Ali SZ.

Cancer Cytopathol. 2013 May;121(5):228-33. doi: 10.1002/cncy.21245. Epub 2012 Oct 5.

Supplemental Content

Support Center